[1]
“INFLUENCE OF COMBINED HYPOLYPIDEMIC THERAPY ON ACHIEVING TARGETED LDL LEVELS IN PATIENTS WITH IBS AND TYPE 2 DIABETES”, Web teach., vol. 4, no. 4, pp. 112–114, Apr. 2026, Accessed: Apr. 26, 2026. [Online]. Available: https://mail.webofjournals.com/index.php/1/article/view/6288